BXRX

Baudax Bio Announces Date of Reconvened Special Meeting

Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders

Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders

Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock

Baudax Bio's ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market

Baudax Bio Announces $11.9 Million Registered Direct Offering